rs587776988
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_001142864.4(PIEZO1):c.7367G>A(p.Arg2456His) variant causes a missense change. The variant allele was found at a frequency of 0.000000715 in 1,398,016 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2456C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001142864.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIEZO1 | NM_001142864.4 | c.7367G>A | p.Arg2456His | missense_variant | 51/51 | ENST00000301015.14 | NP_001136336.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIEZO1 | ENST00000301015.14 | c.7367G>A | p.Arg2456His | missense_variant | 51/51 | 1 | NM_001142864.4 | ENSP00000301015.9 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 7.15e-7 AC: 1AN: 1398016Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 689504
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:8
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 18, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 2456 of the PIEZO1 protein (p.Arg2456His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with hereditary xerocytosis (PMID: 22529292, 23581886, 23973043, 24314002). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 55806). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PIEZO1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects PIEZO1 function (PMID: 23479567, 23487776, 23695678, 28716860). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 14, 2022 | Published functional studies demonstrate a reduced threshold for activation and prolonged channel activation, suggesting a gain-of-function effect (Bae et al., 2013; Glogowska et al., 2017); Not observed in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 25561736, 23973043, 23581886, 24314002, 23695678, 23487776, 22529292, 28716860, 21944700, 31624108, 31040790, 23479567, 29673682, 23972832, 31030808, 29797310, 30655378, 29396846, 31737919, 34201899) - |
Pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Feb 28, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Aug 15, 2023 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Apr 14, 2023 | The PIEZO1 c.7367G>A; p.Arg2456His variant is reported to co-segregate with dehydrated hereditary stomatocytosis in at least 42 individuals from 6 different families (Andolfo 2013, Beneteau 2014, Russo 2018, Sandberg 2014, Shmukler 2014, Zarychanski 2012). In vitro functional analyses demonstrate prolonged cation channel activity leading to reduced osmotic fragility (Albuisson 2013, Andolfo 2013, Bae 2013, Glogowska 2017, Shmukler 2014). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The arginine at codon 2456 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Based on available information, this variant is considered to be pathogenic. References: Albuisson J et al. Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channels. Nat Commun. 2013 4:1884. Andolfo I et al. Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1. Blood. 2013 121:3925-3935, S3921-3912. Bae C et al. Xerocytosis is caused by mutations that alter the kinetics of the mechanosensitive channel PIEZO1. Proc Natl Acad Sci U S A. 2013 110:E1162-1168. Beneteau C et al. Recurrent mutation in the PIEZO1 gene in two families of hereditary xerocytosis with fetal hydrops. Clin Genet. 2014 85:293-295. Shmukler BE et al. Dehydrated stomatocytic anemia due to the heterozygous mutation R2456H in the mechanosensitive cation channel PIEZO1: a case report. Blood Cells Mol Dis. 2014 52:53-54. Zarychanski R et al. Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis. Blood. 2012 120:1908-1915. - |
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jan 23, 2024 | - - |
Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | May 09, 2013 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 15, 2024 | - - |
Lymphatic malformation 6;C4551512:Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema;C5703066:Blood group, ER Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 07, 2024 | - - |
PIEZO1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 20, 2024 | The PIEZO1 c.7367G>A variant is predicted to result in the amino acid substitution p.Arg2456His. This variant has been reported in individual(s) with hereditary xerocytosis and functional studies have shown that this variant results in a gain-of-function affect leading to heightened ion channel activation (Andolfo et al 2013. PubMed ID: 23479567; Albuisson et al 2013. PubMed ID: 23695678). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at